Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collplant Biotechnologies Ltd CLGN

Healthcare Biotechnology
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I... see more

Recent & Breaking News (NDAQ:CLGN)

CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results

PR Newswire November 18, 2021

CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D(TM) for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs

PR Newswire November 15, 2021

CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st

PR Newswire October 14, 2021

CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs

PR Newswire October 11, 2021

36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021

Accesswire October 4, 2021

CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021

PR Newswire September 30, 2021

CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 Conference

PR Newswire September 27, 2021

CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)

PR Newswire September 9, 2021

CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September

PR Newswire September 7, 2021

CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors

PR Newswire August 19, 2021

CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results

PR Newswire August 19, 2021

CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar

PR Newswire August 16, 2021

3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments

GlobeNewswire June 22, 2021

CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs

PR Newswire June 4, 2021

CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million

PR Newswire May 27, 2021

CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs

PR Newswire May 25, 2021

CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors

PR Newswire March 29, 2021

CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020

PR Newswire March 26, 2021

CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference

PR Newswire March 4, 2021

Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants

PR Newswire February 25, 2021